Skip to content
naulon

Not checkedNot checked for notices yet.

46. MICROSURGICAL BREAST RECONSTRUCTION CLINICAL OUTCOMES IN THE COVID-19 ERA

Victor Z. Zhu, MD, MHS, Robert P. Duggan, BS, Julie E. Park, MD and 1 more

Plastic and Reconstructive Surgery, Global Open · 2022

doi:10.1097/01.gox.0000828172.87048.6a (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

PURPOSE: COVID-19 has led to major disruptions in plastic surgery care. Microsurgical breast reconstruction has arguably been affected the most as the procedure is subject to COVID-19 elective surgery bans and often competes for limited intensive care unit beds and nursing staff. Additionally, hypercoagulopathy and vasculitis are known manifestations of COVID-19, which can increase risk for microsurgical vessel anastomosis failure. This study seeks to determine if the COVID-19 pandemic has led to poorer clinical outcomes in microsurgical breast reconstruction due to limited healthcare resources or complications of COVID-19 infection. METHODS: A retrospective, multi-institutional study was conducted using the TriNetX research database, which includes de-identified patient records from 55 healthcare organizations across the United States. Clinical outcomes from microsurgical breast reconstruction patients who had any history of COVID-19 infection and underwent surgery from 3/11/2020-7/31/2021 were compared with a historical control of microsurgical breast reconstruction patients who underwent surgery from 3/11/2018-7/31/2019. RESULTS: 1309 patients had a history of COVID-19 infection and underwent microsurgical breast reconstruction; 2195 patients were included in the historical control. COVID-19 breast reconstruction patients were found to have a higher risk of re-operation within 30 days (OR1.57, p<0.01), vascular complications/flap failure (OR1.52, p=0.02), need for additional vascular procedures (OR1.74, p=0.02), wound dehiscence (OR1.34, p=0.01), and need for revision wound closures (OR2.22, p<0.01). No significant differences were found in venous thromboembolism/pulmonary embolism, infection, and hematoma/seroma between the two groups. CONCLUSION: Microsurgical breast reconstruction during COVID-19 is at increased risk for complications. Surgeons should proceed with caution with these procedures.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.